
New publication "What phases of the drug development framework can epidemiological studies emulate?" at Am J Epi led by me (!), with contributions from @ja_labrecque_, @BarWoolf, Emily, David R, and Sofia: academic.oup.com/aje/advance…

Perplexed sceptic & genetic epidemiologist @mrc_ieu @MRC_BSU @BristolUniPsych. Tutor @LSHTM & @StEdmundsCam.

New publication "What phases of the drug development framework can epidemiological studies emulate?" at Am J Epi led by me (!), with contributions from @ja_labrecque_, @BarWoolf, Emily, David R, and Sofia: academic.oup.com/aje/advance…

New pre-print "Mendelian randomization in a multi-ancestry world: reflections and practical advice" led by @amymariemason - arxiv.org/abs/2510.17554

Really important work (and delighted to help) using pulmonary hypertension as a disease exemplar. Applicable across all rare disease I expect.

New manuscript led by @BarWoolf "A cautionary note on the naive use of general-population biobanks to study pulmonary arterial hypertension" is now published at Euro Respiratory Journal @ERSpublications: pubmed.ncbi.nlm.nih.gov/4096…. Summary follows:

One of my students @StEdmundsCam has a really remarkable story of overcoming adversity to study @Cambridge_Uni. Sadly his scholarship can't fund the rest of his degree so he is trying crowdfunding. Any help would be really appreciated, thank you very much! gofundme.com/f/from-poverty-…

New pre-print online: "Context-stratified Mendelian randomization: exploiting regional exposure variation to explore causal effect heterogeneity and non-linearity", arxiv.org/abs/2507.11088. We propose an alternative approach to assess non-linearity in Mendelian randomization.

Forgot to add the link to the manuscript: academic.oup.com/ajeadvances….

New paper published at AJE Advances: "The role of estimation in Mendelian randomization: should Mendelian randomization investigations provide estimates?" led by @BarWoolf and myself. Brief thread:

Posting a tad late, but @jamesyrmsk and @dpsg108 and I have a new research letter in @intjepidemiol where we use negative controls to illustrate why drug use phenotypes should not be used as exposures in MR studies academic.oup.com/ije/article…

🚨 New preprint awaiting feedback! 🚨 led by the lovely and talented @martaalcalde18 looking at the relationship between PDE5 inhibition and Alzheimer's disease using #mendelianrandomization (spolier: we found nada) medrxiv.org/content/10.1101/…

And the accepted m/s is now out in the AJE! academic.oup.com/aje/advance… Thank you to @htcronje @dpsg108 @stevesphd @LoukasZagkos @LarssonSC Summary can be found
Had a lot of fun presenting our work (accepted this week at the AJE) on exposure miss-identification in MR, and how it results in directionally incorrect conclusions for studies of caffeine consumption at #mrconf24.

Had a lot of fun presenting our work (accepted this week at the AJE) on exposure miss-identification in MR, and how it results in directionally incorrect conclusions for studies of caffeine consumption at #mrconf24.

youtube.com/watch?v=-8Gy0s3m… really enjoyed watching this seminar by @HarvardEpi on measurement error. Lots of food for thought.

Our new study erj.ersjournals.com/content/… with James Perry, Charles Hong @mark_toshner, @stevesphd, @dpsg108, Martin Wilkins, and Chris Rhodes failed to find evidence supporting the use of IL6R inhibitors on pulmonary arterial hypertension.

New Mendelian Randomization from @LoukasZagkos @htcronje @BarWoolf @stevesphd @Yuan_AS @LarssonSC @jotzou @dpsg108 et al.: Long-term increases in circulating #caffeine may reduce bodyweight and the risk of osteoarthrosis and osteoarthritis. shorturl.at/blySV

**Flash Talks Event** Benjamin Woolf @BarWoolf shares his research "Comparison of caffeine consumption behavior with plasma caffeine levels as exposure measures in drug-target Mendelian randomization studies" Vote for your favourite talk: meg-uk.org/flash-talks-2024